T1	Participants 57 125	external genital and perianal warts in different patient populations
T2	Participants 324 355	patients' demographic variables
T3	Participants 427 475	treatment of external genital and perianal warts
T4	Participants 490 530	Male and female immunocompetent patients
T5	Participants 979 1119	subgroups based on variables of gender, baseline wart area, duration of current outbreak of warts, previous wart treatment, and tobacco use.
T6	Participants 1317 1352	external genital and perianal warts
